June 17 is World CDKL5 Day!
Source: Pixabay

June 17 is World CDKL5 Day!

At just two days old, Leita’s son Glyn started having infantile spasms. For the next sixteen years, Glyn’s seizures worsened. Leita also had two other children – twins named Asha…

Continue Reading June 17 is World CDKL5 Day!
Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk
source: pixabay.com

Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk
Tick-Borne Illnesses Are More Prevalent in Summer and It’s Important to Know the Signs
source: pixabay.com

Tick-Borne Illnesses Are More Prevalent in Summer and It’s Important to Know the Signs

Jonathan Rayner works at the University of South Alabama as the Director of the Laboratory of Infectious Diseases. Jonathan has studied ticks since back in 2018. He and his colleagues…

Continue Reading Tick-Borne Illnesses Are More Prevalent in Summer and It’s Important to Know the Signs

Two Novel Sickle Cell Disease Treatments Have Received Orphan Drug and Rare Pediatric Disease Designation

Global Blood Therapeutics (GBT) has just announced that their therapeutics called GBT021601 (GBT601) and inclacumab for sickle cell disease (SCD) have received both Rare Pediatric Disease Designation and Orphan Drug…

Continue Reading Two Novel Sickle Cell Disease Treatments Have Received Orphan Drug and Rare Pediatric Disease Designation

Two New Combination Treatments for Esophageal Squamous Cell Carcinoma Are FDA Approved

The FDA has recently approved combination treatments for those diagnosed with unresectable advanced or metastatic esophageal squamous cell carcinoma. These combination treatments are nivolumab and fluoropyrimidine along with platinum-containing chemotherapy…

Continue Reading Two New Combination Treatments for Esophageal Squamous Cell Carcinoma Are FDA Approved
This Nonprofit’s Clinical Trial Committee Aims to Help Rett Syndrome Drug Development
source: pixabay.com

This Nonprofit’s Clinical Trial Committee Aims to Help Rett Syndrome Drug Development

According to a story from news-medical.net, the International Rett Syndrome Foundation (IRSF) has announced the launch of its Clinical Trial Committee. The committee was implemented with the goal of helping…

Continue Reading This Nonprofit’s Clinical Trial Committee Aims to Help Rett Syndrome Drug Development